Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.55x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.55Latest market snapshot
Implied fair value · at GIII's multiple
$4.9088.8% below market
12.37 SUPN revenue / share×0.40x GIII P/S=$4.90
Market $43.55Implied $4.90
GIII · current priceP/S 0.40x
$27.76Latest market snapshot
Implied fair value · at SUPN's multiple
$246.78789.0% above market
70.09 GIII revenue / share×3.52x SUPN P/S=$246.78
Market $27.76Implied $246.78